Awaiting FDA action on YUTREPIA™ NDA with a PDUFA goal date of May 24, 2025 District Court dismissed cross claim filed by United Therapeutics challenging PH-ILD amendment Fully enrolled Cohort A of ...

A pharmaceutical company that specializes in the production of medication kits used for the treatment of diabetes, ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

Recently approved medications for resistant hypertension, uncomplicated UTIs and menopausal hot flashes show potential as ...

We compared blood pressure (BP, mm Hg) control rates from 6 to 42 months in adults with hypertension who did or did not have antihypertensive treatment initiated (TI) with monotherapy during the first ...

Mexico has reported the first-ever human case of myiasis caused ... The authorities said she is in stable condition and receiving antibiotic treatment. Myiasis is a parasitic infection that ...

This mechanism makes it particularly effective for reducing blood pressure in adults whose hypertension remains uncontrolled with other treatments. TRYVIO also has a low risk of drug-drug ...

(Jim Slosiarek/The Gazette) Coffin said NCCC volunteers have been the “first line of defense.” “When you think about all we've experienced here in Iowa with flooding and tornadoes ...

It is a possible maintenance treatment for advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer after a complete or partial response to first-line platinum-based ...

Pulmonary arterial hypertension (PAH ... avoid compromising their chances of benefiting from effective treatment. This is the first time in the field of PAH treatment trials that an interim ...

The switch back to ozone marks the completion of the first phase of an ozone system ... while chlorine was utilized as the primary water treatment method to meet disinfection regulations.